(Q40171382)

18 September 2017

Assessment of flavaglines as potential chikungunya virus entry inhibitors (English)

1 reference

18 September 2017

0 references

1 reference

5

Sukathida Ubol

1 reference

18 September 2017

7

Duncan R Smith

1 reference

18 September 2017

Phitchayapak Wintachai

1

1 reference

18 September 2017

Frédéric Thuaud

2

1 reference

18 September 2017

Christine Basmadjian

3

1 reference

18 September 2017

Sittiruk Roytrakul

4

1 reference

18 September 2017

Laurent Désaubry

6

1 reference

18 September 2017

1 March 2015

1 reference

Microbiology and Immunology

18 September 2017

1 reference

18 September 2017

59

1 reference

18 September 2017

3

1 reference

18 September 2017

129-141

1 reference

Chikungunya: a re-emerging virus

18 September 2017

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Biology and pathogenesis of chikungunya virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. I. Clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

The Newala epidemic. III. The virus: isolation, pathogenic properties and relationship to the epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Chikungunya disease outbreak, Reunion Island.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Estimating Chikungunya prevalence in La Réunion Island outbreak by serosurveys: Two methods for two critical times of the epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Tracing the path of Chikungunya virus--evolution and adaptation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Chikungunya in Southeast Asia: understanding the emergence and finding solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Chikungunya and dengue autochthonous cases in Europe, 2007-2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Characterization of reemerging chikungunya virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Chikungunya virus infection of cell lines: analysis of the East, Central and South African lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Active infection of human blood monocytes by Chikungunya virus triggers an innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Endocytosis of chikungunya virus into mammalian cells: role of clathrin and early endosomal compartments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Identification of prohibitin as a Chikungunya virus receptor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Synthetic analogue of rocaglaol displays a potent and selective cytotoxicity in cancer cells: involvement of apoptosis inducing factor and caspase-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Prohibitin, an antiproliferative protein, is localized to mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Prohibitin function within mitochondria: essential roles for cell proliferation and cristae morphogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Prohibitin ligands in cell death and survival: mode of action and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Vi polysaccharide of Salmonella typhi targets the prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Identification and characterization of prohibitin as a receptor protein mediating DENV-2 entry into insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Investigation of the Cry4B-prohibitin interaction in Aedes aegypti cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Chimeric alphavirus vaccine candidates for chikungunya

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Chikungunya virus and prospects for a vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Flavaglines alleviate doxorubicin cardiotoxicity: implication of Hsp27

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Recent advances in the biology and chemistry of the flavaglines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

The natural anticancer compounds rocaglamides inhibit the Raf-MEK-ERK pathway by targeting prohibitin 1 and 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Chemical affinity matrix-based identification of prohibitin as a binding protein to anti-resorptive sulfonyl amidine compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Synthesis and SAR of sulfonyl- and phosphoryl amidine compounds as anti-resorptive agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Involvement of ATP synthase β subunit in chikungunya virus entry into insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Co-localization of constituents of the dengue virus translation and replication machinery with amphisomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Reversal of obesity by targeted ablation of adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Expression of prohibitins on the surface of activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Prohibitins are involved in protease-activated receptor 1-mediated platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Severe acute respiratory syndrome coronavirus nonstructural protein 2 interacts with a host protein complex involved in mitochondrial biogenesis and intracellular signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Identification of the cellular prohibitin 1/prohibitin 2 heterodimer as an interaction partner of the C-terminal cytoplasmic domain of the HIV-1 glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Recombinant viral capsid protein VP1 suppresses migration and invasion of human cervical cancer by modulating phosphorylated prohibitin in lipid rafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12230

Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218.

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Mosquito-borne haemorrhagic fevers of South and South-East Asia

1 reference

12 December 2020

Flavaglines as potent anticancer and cytoprotective agents

1 reference

12 December 2020

A major epidemic of chikungunya virus infection on Reunion Island, France, 2005-2006.

1 reference

12 December 2020

Seroprevalence of Chikungunya virus (CHIKV) infection on Lamu Island, Kenya, October 2004.

1 reference

12 December 2020

Seroprevalence of Chikungunya virus infection on Grande Comore Island, union of the Comoros, 2005.

1 reference

12 December 2020

Identifiers

DOI

10.1111/1348-0421.12230

1 reference

18 September 2017

1 reference